BELLICUM PHARMACEUTICALS, INC Annual Nonoperating Income (Expense) in USD from 2013 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Bellicum Pharmaceuticals, Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2013 to 2022.
  • Bellicum Pharmaceuticals, Inc Nonoperating Income (Expense) for the quarter ending September 30, 2023 was $10K.
  • Bellicum Pharmaceuticals, Inc Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was $1.45M, a 82.9% decline year-over-year.
  • Bellicum Pharmaceuticals, Inc annual Nonoperating Income (Expense) for 2022 was $2.01M, a 86.7% decline from 2021.
  • Bellicum Pharmaceuticals, Inc annual Nonoperating Income (Expense) for 2021 was $15.2M, a 65.5% decline from 2020.
  • Bellicum Pharmaceuticals, Inc annual Nonoperating Income (Expense) for 2020 was $44M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $2.01M -$13.2M -86.7% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-31
2021 $15.2M -$28.8M -65.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $44M +$69.1M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 -$25.1M -$22.5M -877% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 -$2.57M +$1.82M +41.5% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 -$4.39M -$3.53M -410% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
2016 -$861K -$1.45M -247% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-13
2015 $587K +$26.7M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-13
2014 -$26.1M -$26.1M -55489% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-13
2013 -$47K Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.